(2-8 mg/day). Doxazosin was recently withdrawn from this trial after an interim analysis showed the secondary end point of combined cardiovascular disease to be 25% greater in patients on ...

8 mg Cardura XL (doxazosin) extended release tablets, 4 mg The distributor is listed as Viatris Speciality LLC in Morgantown, West Virginia, and the FDA’s notice says the recall affects ...

all acarbose-treated patients experienced a significant reduction in BMI (-3.6%), HbA 1c (-9.9%), FPG (-8.4%) and PPG (-16.3%); however, only those patients who were also treated with doxazosin ...